BIO-TECHNE Corp (TECH)

↓ Download CSV

CIK 0000842023 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated MN
  • Fiscal year ends Jun 30

In fiscal 2025, BIO-TECHNE Corp reported revenue of $1.22B, up 5.2% from the prior year. The company was profitable, with a net margin of 6.0% and a gross margin of 64.8%.

Key ratios (FY2025)

64.8%
Gross margin
8.4%
Operating margin
6.0%
Net margin
3.8%
Return on equity
+5.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.22B$1.16B$1.14B$1.11B$931.03M$738.69M$714.01M$642.99M$563.00M
Cost of Revenue$429.36M$389.33M$366.89M$349.10M$298.18M$255.50M$240.51M$210.85M$188.46M$162.36M
Gross Profit$790.27M$769.73M$769.82M$756.50M$632.85M$483.19M$473.49M$432.14M$374.54M$336.66M
Operating Income$102.25M$206.69M$298.94M$296.59M$237.30M$157.42M$146.72M$136.18M$120.58M$150.59M
Net Income$73.40M$168.10M$285.26M$272.05M$140.41M$229.30M$96.07M$126.15M$76.09M$104.48M
EPS (Diluted)$0.46$1.05$1.76$1.66$0.87$5.82$2.47$3.31$2.03$2.80
Total Assets$2.56B$2.70B$2.64B$2.29B$2.26B$2.03B$1.88B$1.59B$1.56B$1.13B
Shareholders' Equity$1.92B$2.07B$1.97B$1.70B$1.57B$1.38B$1.17B$1.08B
Cash & Equivalents$162.19M$151.79M$180.57M$172.57M$199.09M$146.62M$100.89M$121.99M$91.61M$64.24M
Operating Cash Flow$287.56M$298.98M$254.39M$325.27M$352.16M$205.22M$181.62M$170.37M$143.72M$144.16M
Capital Expenditures$31.01M$62.88M$38.24M$44.91M$44.30M$51.74M$25.41M$20.93M$15.18M$16.90M
Shares Outstanding159.72M160.77M161.85M164.11M161.93M39.40M38.89M38.05M37.50M37.33M
Dividends Per Share$0.32$0.32$0.32$0.32$0.32$1.28$1.28$1.28$1.28